
Piet Ost
@piet_ost
Followers
4K
Following
20K
Media
502
Statuses
14K
Radiation Oncologist, Iridium Network, GZA Ziekenhuizen, Antwerp. Associate professor Ghent University, Belgium.
Gent, België
Joined August 2015
📢 STORM trial breaking results at #ESTRO25!. 🧪 MDT vs ENRT+MDT for nodal oligorecurrent PCa. 🧬 ENRT+MDT:.✅ Superior bRFS (57% vs 41%, p=0.014).✅ Superior pelvic control (lrRFS 85% vs 62%, p=0.006).✅ Superior MFS (76% vs 63%, p=0.06).❌ No increase in ≥G2 GU/GI toxicity
17
100
201
RT @DrYukselUrun: In high-risk prostate cancer, radiotherapy plus ADT significantly reduces the risk of distant metastasis compared to surg….
0
50
0
RT @OncoAlert: The OncoAlert WEEKLY RoundUp 🚨.Covering the TOP of the week July 11-17, 2025 . 👉REGISTER at OR ht….
0
15
0
RT @GSCollins: NEW PAPER in @bmj_latest "Dealing with continuous variables and modelling non-linear associations in healthcare data: pract….
0
106
0
RT @BenVanCalster: Dit moet meer onder de aandacht komen. Halfbakken onderzoek, belastinggeld dat massaal aan uitgeverijen gegeven wordt. D….
theguardian.com
Widespread mockery of AI-generated rat with giant penis in one paper brings problem to public attention
0
6
0
RT @DrAsifQasim: Well done @ERunswickBMA on @BBCr4today - clear explanation as to why resident doctors need pay restoration . Despite @bbcn….
0
52
0
RT @ebludmir: @ChadTangMD & I happy to report: ph2 basket EXTEND-OP trial has enrolled and randomized 150 patients in the last year since o….
0
12
0
RT @CZamboglou: Excited to share our newest paper on digital pathology AI biomarkers in prostate cancer RT. In this work we:. ▶️performed a….
0
16
0
RT @ESTRO_RT: The 10-year results of the HYPO-RT-PC trial, presented at #ESTRO25, confirm that ultra-hypofractionated #radiotherapy is a sa….
0
23
0
RT @drdavidpalma: Some ask if patients with limited metastatic disease can be cured. The answer is clearly yes. We’ve known that since th….
0
18
0
RT @yekeduz_emre: Can metformin boost survival in metastatic hormone-sensitive prostate cancer?. 🔑 : A win for metabolic health, but not a….
0
20
0
RT @alongi_filippo: Brilliant definition of a way to use SBRT/SRS as a strategic tool in cancer treatment management. .
0
13
0
RT @B_Tomasik: 🚨Happy to share that I'm launching a new study called RAPSTAR - the first randomised, multicentre phase III trial comparing….
0
14
0
RT @specialistkrant: Beperking van supplementen kan mutualiteiten tot 100 miljoen euro opleveren @bvastweets @DeClercqLuc @IrinaDeKnop….
despecialist.eu
De voorstellen van Solidaris om ereloonsupplementen te plafonneren en zelfs tarieven op niet-terugbetaalde prestaties te beperken, worden voorgesteld als sociale maatregelen voor meer betaalbare...
0
5
0
RT @Bvancraeynest: Over die meerwaardebelasting:.- fiscaliteit nog complexer.- helpt niet om groeipotentieel te versterken (integendeel).-….
0
30
0
RT @_ShankarSiva: #SABR2025 registrations are open #radonc!! - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th….
sabrsymposium.com
Peter MacCallum Cancer Centre has been running highly successful symposia on Stereotactic Ablative Body Radiation Therapy (SABR) since 2014. In November we will once again host the SABR Symposium in...
0
24
0